Search
Close this search box.

Introduction to GERD

What is GERD?

Gastroesophageal reflux disease, or GERD, is very common, affecting up to 1 in 5 or more of adult men and women in the U.S. population. It also occurs in children. Although common, the disease often is unrecognized – its symptoms misunderstood. This is unfortunate because GERD is generally a treatable disease, though serious complications can result if it is not treated properly.

Heartburn is the most frequent – but not the only – symptom of GERD. (The disease may be present even without apparent symptoms.) Heartburn is not specific to GERD and can result from other disorders that occur inside and outside the esophagus. All too often, GERD is either self-treated or mistreated.

GERD is a chronic disease. Treatment usually must be maintained on a long-term basis, even after symptoms have been brought under control. Issues of daily living and compliance with long-term use of medication need to be addressed as well. This can be accomplished through follow-up and education.

GERD is often characterized by painful symptoms that can undermine an individual’s quality of life. Various methods to effectively treat GERD range from lifestyle measures to the use of medication or surgical procedures.

It is essential for individuals who suffer the chronic and recurrent symptoms of GERD to seek an accurate diagnosis, to work with their physician, and to receive the most effective treatment available.

Learn more about talking with your doctor

 


Refractory Gastroesophageal Reflux Disease rGERD Survey
IFFGD has been working with a pharmaceutical company to create a survey to better understand the illness experience of those with rGERD. Refractory Gastroesophageal Reflux Disease (rGERD) is very common and may affect up to 40% of people who use a proton pump inhibitor (PPI) once daily.  You can participate in this survey here.


Adapted from IFFGD Publication: GERD Brochure. Contributors: Joel E. Richter, M.D., F.A.C.P., M.A.C.G., Director, USF Division of Digestive Diseases and Nutrition; Director, USF Joy McCann Culverhouse Center for Swallowing Disorders; Endowed Chair, Division of Internal Medicine; and Professor, Department of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL; Philip O. Katz, M.D., F.A.C.G., Head, Esophageal Testing Laboratory, Albert Einstein Medical Center, Philadelphia, PA; and J. Patrick Waring, M.D., Attending Physician, Digestive Healthcare of Georgia, Piedmont Hospital, Atlanta, GA.

Share this page
Topics of this article
Was this article helpful?

IFFGD is a nonprofit education and research organization. Our mission is to inform, assist, and support people affected by gastrointestinal disorders.

Our original content is authored specifically for IFFGD readers, in response to your questions and concerns.

If you found this article helpful, please consider supporting IFFGD with a small tax-deductible donation.

Related Information
rGERD Survey

Do you suffer from Refractory Gastroesophageal Reflux Disease (rGERD)? IFFGD has been working with the International Working Group for the Classification of Oesophagitis (IWGCO) to create

Read More »
Research News

IFFGD is a leader in the fight for more research to improve diagnostic and treatment options for gastrointestinal (GI) disorders. With donations from people like

Read More »
Personal Stories
rGERD Survey

Do you suffer from Refractory Gastroesophageal Reflux Disease (rGERD)? IFFGD has been working with the International Working Group for the Classification of Oesophagitis (IWGCO) to create

Read More »
Research News

IFFGD is a leader in the fight for more research to improve diagnostic and treatment options for gastrointestinal (GI) disorders. With donations from people like

Read More »
Skip to content